Uterine Fibroids clinical trials at UC Cancer
1 research study open to eligible people
open to eligible females ages 18 years and up
The purpose of this research study is to find out which type of transversus abdomens plane (TAP) and block (bupivacaine, liposomal bupivacaine or liposomal bupivacaine with re-dosing at 48-60 hours) improves your pain control and lowers your risk of post-operative common side effects of surgery and narcotic pain medications.
at UC Irvine
Our lead scientists for Uterine Fibroids research studies include Jill H Tseng, MD.